ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1
Proceedings of the National Academy of Sciences · 2023
DOI: 10.1073/pnas.2210418120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Benjamin Mayro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710. Hauptthemen laut MEDLINE: Gene Expression Regulation, Transcription Factors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The hypoxia-inducible factor 1-α (HIF-1α) enables cells to adapt and respond to hypoxia (Hx), and the activity of this transcription factor is regulated by several oncogenic signals and cellular stressors. While the pathways controlling normoxic degradation of HIF-1α are well understood, the mechanisms supporting the sustained stabilization and activity of HIF-1α under Hx are less clear. We report that ABL kinase activity protects HIF-1α from proteasomal degradation during Hx. Using a fluorescence-activated cell sorting (FACS)-based CRISPR/Cas9 screen, we identified HIF-1α as a substrate of the cleavage and polyadenylation specificity factor-1 (CPSF1), an E3-ligase which targets HIF-1α for degradation in the presence of an ABL kinase inhibitor in Hx. We show that ABL kinases phosphorylate and interact with CUL4A, a cullin ring ligase adaptor, and compete with CPSF1 for CUL4A binding, leading to increased HIF-1α protein levels. Further, we identified the MYC proto-oncogene protein as a second CPSF1 substrate and show that active ABL kinase protects MYC from CPSF1-mediated degradation. These studies uncover a role for CPSF1 in cancer pathobiology as an E3-ligase antagonizing the expression of the oncogenic transcription factors, HIF-1α and MYC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC 27710.
- Duke Cancer Institute, Duke University School of Medicine, Durham, NC 27710.
- Department of Orthopedic Surgery, Duke University School of Medicine, Durham, NC 27710.
ORCID-Profile: Benjamin Mayro, Jacob P Hoj, Christian G Cerda-Smith, Haley M Hutchinson, Michael W Caminear, Hannah L Thrash, Suzanne E Wardell, Donald P McDonnell, Kris C Wood, Ann Marie Pendergast
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
- HHS | National Institutes of Health
- U.S. Department of Defense
Zitieren
APA
Mayro, B., Hoj, J. P., Cerda-Smith, C. G., Hutchinson, H. M., Caminear, M. W., Thrash, H. L., Winter, P. S., Wardell, S. E., McDonnell, D. P., Wu, C., Wood, K. C., & Pendergast, A. M. (2023). ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2210418120
Vancouver
Mayro B, Hoj JP, Cerda-Smith CG, Hutchinson HM, Caminear MW, Thrash HL, et al. ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2210418120
BibTeX
@article{Mayro2023,
author = {Mayro, Benjamin and Hoj, Jacob P and Cerda-Smith, Christian G and Hutchinson, Haley M and Caminear, Michael W and Thrash, Hannah L and Winter, Peter S and Wardell, Suzanne E and McDonnell, Donald P and Wu, Colleen and Wood, Kris C and Pendergast, Ann Marie},
title = {ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1},
journal = {Proceedings of the National Academy of Sciences},
year = {2023},
doi = {10.1073/pnas.2210418120}
}
EUVIMED